Dr. Aaron Savar, MD

Dr. Savar practices at Melrose Family Health Center in Los Angeles, California.

Dr. Savar's NPI, 1124182662, was assigned on December 20, 2006. Dr. Savar graduated from Boston University School Of Medicine in 2003. Dr. Savar holds Massachusetts license 225926.

Dr. Savar's primary practice is Melrose Family Health Center, at 5205 Melrose Avenue, 1st And 2nd Floors, Los Angeles, CA 90038 in Los Angeles County. The practice phone is (323) 330-1638.

Dr. Savar's primary practice is Melrose Family Health Center in Los Angeles, California. Dr. Savar is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Saban Community Clinic. Dmand AI also links Dr. Savar to 3 more medical groups and 2 group practices and clinics, each named with a free account. Dr. Savar's employer is on file too: a community health center (fqhc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Savar practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Savar's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Savar is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Savar's licenses on file in 3 states: Massachusetts, California and Texas.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Savar treats.

CMS data shows 2,687 Medicare services from Dr. Savar across 20 procedure codes in 2024, for 757 Medicare patients. Medicare paid $198,688 for them.

CMS counts 757 Medicare patients who saw Dr. Savar in 2024. The largest group is 75 to 84, with 340 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Savar's median patient age at 72, with 62% women.

In 2024, Dr. Savar wrote 662 Medicare Part D claims for 206 patients. 65% of them were for generic drugs. CMS names the drug for 592 of them, across 17 drugs with 11 or more claims each, at $62,281 in total drug cost. In 2023, CMS named 593 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Savar for performance year 2024, reported individually. Dr. Savar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 60 procedures of cataract surgery by Dr. Savar, more than 66% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 22 papers to Dr. Savar, published from 2009 to 2023. 2009 was the busiest year, with 2. The most frequent topics are Eyelid Neoplasms, Conjunctival Neoplasms and Melanoma. Dr. Savar has published most often in Ophthalmic Plast Reconstr Surg. Dr. Savar's most frequent co-authors are Bita Esmaeli, MD, Doina Ivan, MD and Victor G. Prieto, MD, PhD.

CMS Open Payments shows 15 general payments to Dr. Savar from 8 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 68% of the total. NotalVision paid the most, $300.

Dmand AI lists 3 awards for Dr. Savar, most recently CMS Stage 1 EHR in 2013.

Dr. Savar graduated from Boston University School Of Medicine in 2003. Dr. Savar is a member of AAO and ACS.

Dr. Savar is in network with 15 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.